• Nachrichtendetail
• 

11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	SANOFI SA INHABER EO 2	920657	Xetra	90,140	27.06.24 09:04:10	-0,790	-0,87%	89,730	89,790	90,140	90,930
	REGENERON PHARMAC.DL-,001	881535	Frankfurt	993,000	27.06.24 08:12:54	-13,500	-1,34%	994,200	1.006,000	993,000	1.006,500